Saxagliptin mitigates airway inflammation in a mouse model of acute asthma via modulation of NF-kB and TLR4.

Autor: Helal MG; Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Egypt. Electronic address: manargamal2008@gmail.com., Megahed NA; Dep. of Pathology, Faculty of Medicine, Mansoura University, Egypt., Abd Elhameed AG; Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Egypt.
Jazyk: angličtina
Zdroj: Life sciences [Life Sci] 2019 Dec 15; Vol. 239, pp. 117017. Date of Electronic Publication: 2019 Oct 31.
DOI: 10.1016/j.lfs.2019.117017
Abstrakt: Saxagliptin (Saxa), a dipeptidyl dipeptidase-4 (DPP-4) inhibitor, is widely used for the treatment of type 2 diabetes mellitus. It has been documented to have immunomodulatory and anti-inflammatory actions. Our objective was to delineate the protective effect and the underlying mechanism of Saxa-in comparison with Dexamethasone (Dexa) - in airway inflammation induced by ovalbumin (OVA) in mice.
Methods: Mice were OVA-sensitized and challenged for the induction of acute asthma. Mice were orally administrated Saxa or Dexa. Total and differential cell counts, lactate dehydrogenase (LDH) and total protein concentrations were assessed in bronchoalveolar lavage fluid (BALF). The toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-kB), reduced glutathione (GSH), and total nitrate/nitrite products (NOx) levels as well as myeloperoxidase (MPO) activity in lung tissues were measured. Histopathological examination of the lung specimens was carried out using the hematoxylin and eosin (H & E) staining.
Results: Histopathological examination revealed that both Saxa and Dexa ameliorated OVA-induced inflammatory changes and significantly reduced total and differential leukocyte counts, LDH and total protein level in BALF upon comparison with OVA group. In addition, both treatments significantly mitigated OVA-induced oxidative stress as evidenced by diminished lung NOx level and MPO activity and elevated GSH level. The elevation of TLR4 and NF-kB levels in lung tissue were ameliorated by Saxa and Dexa administration.
Conclusion: Saxa had marked antiasthmatic effect in OVA-induced allergic asthma through modulation of TLR4 and NF-κB signaling. Also, Saxa may represent a promising therapeutic agent for acute allergic asthma.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: